Stephen Liu

News

Sports

Arts

Opinion

The Quad

Photo

Video

Illustrations

Cartoons

Graphics

The Stack

PRIME

Enterprise

Interactives

Podcasts

Games

Classifieds

Print issues

Budget Cuts Explained,

Dance Marathon 2026

robots

The treatment is a form of chimeric antigen receptor T cell therapy, in which a synthetic gene is added to T cells that recognize infectious substances and mount an immune response. (Daily Bruin file photo)

https://dailybruin.com/2018/02/13/ucla-health-certified-to-offer-immune-cell-modification-therapy/web-ns_-car-t-file_-jpg/

twitter:card

twitter:description

twitter:title

twitter:site

https://wp.dailybruin.com/images/2018/02/web.ns_.car-t.file_.jpg

twitter:image

twitter:creator

web.ns.car-t.file.jpg - Daily Bruin

Science & Health

db-story-b

Daily Bruin

UCLA Health certified to offer immune cell modification therapy - Daily Bruin

UCLA Health certified to offer immune cell modification therapy

max-snippet:-1, max-image-preview:large, max-video-preview:-1

UCLA Health has received certification to provide a therapy that genetically modifies patients’ own cells to attack cancer, the university announced Friday. The Food and Drug Administration approved the treatment, marketed as Yescarta, in October for patients with a type of blood cancer called large B cell lymphoma.

https://dailybruin.com/2018/02/13/ucla-health-certified-to-offer-immune-cell-modification-therapy/

Wednesday, March 11, 2026

IN THE NEWS:

UCLA Health certified to offer immune cell modification therapy

By Stephen Liu

Feb. 13, 2018 11:03 p.m.